Vaccine hopes boosted shared, but  entiment was still cautious ahead of a big week of central bank meetings in UK, Japan and the United States.

AstraZeneca announced it has resumed British clinical trials of its COVID-19 vaccine at the weekend, after getting the green light from safety watchdogs.

This is one of the most advanced in development.

The late-stage trials of the experimental vaccine, developed with researchers from the University of Oxford, were suspended last week after an illness in a study subject in Britain, casting doubts on an early rollout.

A vaccine has long been awaited to help pull the world out of a coronavirus-induced lockdown.

“The reopening of the global economy is enticing us to recommend a trade going long a basket of 14 laggard ‘back to work’ stocks versus a basket of 14 high-flying ‘COVID-19 winners’,” BCA Research wrote in a note.

“While we maintain a cyclical and secular bullish outlook on the broad market, a short-term correction due to technical and (geo) political reasons is likely on the cards,” it said

“A playable short-term pullback is in order.”

FOLLOW EXPRESS.CO.UK BELOW FOR LIVE UPDATES:

9.15am update: European markets start strong

Like FTSE, European markets have started the day brightly.

Euronext 100 is up 0.70%, CAC 40 is up 0.77%, DAX is up 0.53% and Swiss Market Index is up 0.30%.

8.20am update: FTSE soars on open

FTSE has soared on open this morning, growing 70 points in just a matter of minutes.

The UK index closed at 6,043 on Friday afternoon, after a productive week during which it rose from 5,799.

This morning the index has continued its bright form, rising from 6,043 to 6,076.

More to follow…

source: express.co.uk

LEAVE A REPLY

Please enter your comment!
Please enter your name here